Junctophilin-1 inhibitors represent a class of chemical compounds that have gained prominence in the field of cellular biology and excitation-contraction coupling research. These inhibitors are specifically designed to target and modulate the activity of junctophilin-1 (JP-1), a protein that plays a critical role in the formation of specialized membrane structures known as junctional complexes within muscle cells. Junctional complexes are essential for the precise communication between the sarcolemma (muscle cell membrane) and the sarcoplasmic reticulum, a specialized intracellular organelle involved in calcium storage and release. JP-1 serves as a structural scaffold, bridging the physical gap between these two membranes and facilitating the transmission of electrical signals to trigger muscle contraction.
Junctophilin-1 inhibitors exert their effects by interfering with the function or expression of JP-1, disrupting the integrity of junctional complexes and impairing the efficiency of excitation-contraction coupling in muscle cells. This disruption can have profound implications for muscle physiology and contractile function. Researchers employ JP-1 inhibitors as invaluable tools to investigate the specific role of JP-1 in muscle cell function and to better understand the molecular mechanisms underlying excitation-contraction coupling. While the specific applications and broader implications of JP-1 inhibitors are subjects of ongoing research, their utility in unraveling the intricacies of muscle cell physiology and membrane interactions is crucial in advancing our knowledge of cellular biology and muscle function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and prevents RNA synthesis, which could lead to a reduction in JPH1 mRNA and protein levels. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Stabilizes the DNA-topoisomerase I complex, causing DNA damage and potentially decreasing JPH1 transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, which is responsible for mRNA synthesis, potentially leading to decreased JPH1 mRNA. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Forms cross-links within DNA strands, hindering DNA replication and transcription, possibly reducing JPH1 expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Impairs mRNA synthesis by acting as an adenosine analogue, which could decrease JPH1 mRNA levels and protein synthesis. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerase, which may result in cell cycle arrest and a consequent decrease in JPH1 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Causes DNA strand breaks by inhibiting topoisomerase II, potentially resulting in decreased JPH1 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferase, potentially leading to changes in gene expression, including that of JPH1. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor that could alter JPH1 expression by affecting epigenetic regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can alter chromatin structure and gene expression, potentially impacting JPH1 expression. | ||||||